Enzo Biochem Announces Expanded Distribution Agreement with Japan’s Cosmo Bio
News Mar 21, 2012
In addition, Enzo will make Cosmo Bio’s extensive catalog of Japanese manufactured research biotools, for which it is a leading distributor, available to researchers around the world through Enzo’s extensive global distribution network. This arrangement materially widens the span of biosciences products offered by both companies and increases the accessibility of the collective portfolio to customers worldwide.
“Cosmo Bio is a leading distributor of research products and custom services to Japan’s academic, pharmaceutical and biotech communities, and expansion of our relationship with Cosmo Bio will provide Japan’s researchers with improved access to a broader range of Enzo products backed by extensive and efficient technical and sales support,” said Barry Weiner, President of Enzo Biochem.
Dr. Haruhisa Sakurai, a company Director at Cosmo Bio Co., Ltd. commented that "we are proud to strengthen our relationship with Enzo Life Sciences. Cosmo Bio and Enzo share similar company core values in their dedication to supplying quality products and delivering outstanding customer service to the world marketplace. Our expanded alliance with Enzo and the introduction of thousands of Japanese manufactured biotools to be offered by Cosmo Bio’s export division through Enzo Life Sciences’s worldwide distribution system further expands the choices and opportunities available to our customers worldwide.”
Combining Different Malaria Vaccines Could Reduce Cases by 91%News
Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE